Bain Capital injects up to $300 million in Cardurion Pharmaceuticals
Bain joins existing investors Takeda Pharmaceuticals and Polaris Partners in supporting the evolution of the cardiovascular biotechnology company.
Nearly there!
A verification email is on its way to you. Please check your spam or junk folder just in case.
If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: subscriptions@pei.group .-
Sign in or Register
-
Issues with signing in? Click here
Don't have an account? Register now
-
